Six year survey of screening for Down's syndrome by maternal age and mid-trimester ultrasound scans

被引:40
作者
Howe, DT [4 ]
Gornall, R
Wellesley, D
Boyle, T
Barber, J
机构
[1] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England
[2] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England
[3] Salisbury Dist Hosp, Cytogenet Lab, Salisbury SP2 8BJ, Wilts, England
[4] Princess Anne Hosp, Wessex Maternal & Fetal Med Unit, Southampton SO16 5YA, Hants, England
关键词
D O I
10.1136/bmj.320.7235.606
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the effectiveness of antenatal screening for Down's syndrome by maternal age and routine mid-pregnancy ultrasound scanning. Design Retrospective six year survey. Setting Maternity units of a district general hospital. Subjects Pregnant women booked for delivery in hospital between 1 January 1993 and 31 December 1998. Main outcome measures All cases of Down's syndrome occurring in district identified from regional congenital anomaly register and cytogenetic laboratory records. Women's case notes were examined to identify indication for karyotyping, gestation at diagnosis, and outcome of pregnancy. Results 31 259 deliveries occurred during study period, and 57 cases of Down's syndrome were identified, foul in failed pregnancies and 53 in ongoing pregnancies or in neonates. The analysis was confined to ongoing pregnancies or liveborn children. Invasive antenatal tests were performed in 6.6% (2053/31 259), and 68% (95%, confidence interval 56% to 80%) of cases of Down's syndrome were detected antenatally, giving a positive predictive value of 1.8%. There were 17 undetected cases, and in seven of these the women had declined an offer of invasive testing. In women aged less than 35 years the detection rate was 53% (30% to 76%). Most of the cases detected in younger women followed identification of ultrasound anomalies. Conclusions The overall detection rate was considerably higher than assumed ill demonstration projects for serum screening: As a result, the benefits of serum screening are much less than supposed. Before any new methods to identify Down's syndrome are introduced, such as nuchal translucency or first trimester serum screening, the techniques should be tested in properly controlled trials.
引用
收藏
页码:606 / 610
页数:5
相关论文
共 38 条
[1]   DOWNS-SYNDROME - RECENT TRENDS IN THE UNITED-STATES [J].
ADAMS, MM ;
ERICKSON, JD ;
LAYDE, PM ;
OAKLEY, GP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 246 (07) :758-760
[2]  
BECKHUIS J, 1993, THESIS GRONINGEN U G
[3]   A PROSPECTIVE TRIAL OF PRENATAL SCREENING FOR DOWN-SYNDROME BY MEANS OF MATERNAL SERUM ALPHA-FETOPROTEIN, HUMAN CHORIONIC-GONADOTROPIN, AND UNCONJUGATED ESTRIOL [J].
BURTON, BK ;
PRINS, GS ;
VERP, MS .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 169 (03) :526-530
[4]  
Cans C, 1998, PRENATAL DIAG, V18, P683, DOI 10.1002/(SICI)1097-0223(199807)18:7<683::AID-PD327>3.0.CO
[5]  
2-G
[6]  
CHENG EY, 1993, OBSTET GYNECOL, V81, P72
[7]  
Crossley J A, 1994, J Med Screen, V1, P180
[8]   BIRTH PREVALENCE OF DOWNS-SYNDROME IN ENGLAND AND WALES [J].
CUCKLE, H ;
NANCHAHAL, K ;
WALD, N .
PRENATAL DIAGNOSIS, 1991, 11 (01) :29-34
[9]  
DAVIES T, 1991, BRIT MED J, V303, P312
[10]   SERUM SCREENING FOR DOWNS-SYNDROME [J].
DAWSON, AJ ;
JONES, G ;
MATHARU, MS ;
REYNOLDS, TM ;
PENNEY, MD ;
JOHN, R ;
CREASY, M ;
GREGORY, P .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1993, 100 (09) :875-877